1 168 133 A RANDOMIZED CONTROLLED DOSING STUDY OF IYENGAR YOGA AND COHERENT BREATHING FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER: IMPACT ON SUICIDAL IDEATION AND SAFETY FINDINGS. BACKGROUND: YOGA INTERVENTIONS OFFER PROMISE FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD), YET THEIR SAFETY AND POTENTIAL IMPACT ON SUICIDAL IDEATION (SI) HAVE NOT BEEN WELL DOCUMENTED. THIS STUDY EVALUATED THE SAFETY OF A RANDOMIZED CONTROLLED DOSE-FINDING TRIAL OF IYENGAR YOGA PLUS COHERENT BREATHING FOR INDIVIDUALS WITH MDD, AS WELL AS THE POTENTIAL EFFECTS OF THE INTERVENTION ON SI WITHOUT INTENT. METHODS: PARTICIPANTS WITH BECK DEPRESSION INVENTORY-II (BDI-II) SCORES >/=14 AND A DIAGNOSIS OF MDD (USING DSM-IV CRITERIA) WERE RANDOMIZED TO EITHER A LOW DOSE GROUP (LDG) OR HIGH DOSE GROUP (HDG) AND RECEIVED A 12-WEEK MANUALIZED INTERVENTION. THE LDG INCLUDED TWO 90-MIN YOGA CLASSES PLUS THREE 30-MIN HOMEWORK SESSIONS WEEKLY. THE HDG OFFERED THREE 90-MIN CLASSES PLUS FOUR 30-MIN HOMEWORK SESSIONS WEEKLY. RESULTS: THIRTY-TWO INDIVIDUALS WITH MDD WERE RANDOMIZED, OF WHICH 30 COMPLETED THE PROTOCOL. AT SCREENING, SI WITHOUT INTENT WAS ENDORSED ON THE BDI-II BY 9 PARTICIPANTS; AFTER COMPLETING THE INTERVENTION, 8 OUT OF 9 REPORTED RESOLUTION OF SI. THERE WERE 17 ADVERSE EVENTS POSSIBLY-RELATED AND 15 DEFINITELY-RELATED TO THE INTERVENTION. THE MOST COMMON PROTOCOL-RELATED ADVERSE EVENT WAS MUSCULOSKELETAL PAIN, WHICH RESOLVED OVER THE COURSE OF THE STUDY. CONCLUSIONS: THE IYENGAR YOGA PLUS COHERENT BREATHING INTERVENTION WAS ASSOCIATED WITH THE RESOLUTION OF SI IN 8 OUT OF 9 PARTICIPANTS, WITH MILD SIDE EFFECTS THAT WERE PRIMARILY MUSCULOSKELETAL IN NATURE. THIS PRELIMINARY EVIDENCE SUGGESTS THAT THIS INTERVENTION MAY REDUCE SI WITHOUT INTENT AND BE SAFE FOR USE IN THOSE WITH MDD. 2018 2 2755 33 YOGA PRACTICE REDUCES THE PSYCHOLOGICAL DISTRESS LEVELS OF PRISON INMATES. BACKGROUND: PSYCHIATRIC ILL-HEALTH IS PREVALENT AMONG PRISON INMATES AND OFTEN HAMPERS THEIR REHABILITATION. REHABILITATION IS CRUCIAL FOR REDUCING RECIDIVISTIC OFFENDING. A FEW STUDIES HAVE PRESENTED EVIDENCE OF THE POSITIVE EFFECT OF YOGA ON THE WELL-BEING OF PRISON INMATES. THE CONCLUSION OF THOSE PREVIOUS STUDIES THAT YOGA IS AN EFFECTIVE METHOD IN THE REHABILITATION PROCESS OF INMATES, AND DESERVES AND REQUIRES FURTHER ATTENTION. AIMS: THE CURRENT STUDY AIMED TO EVALUATE THE EFFECT OF 10 WEEKS OF YOGA PRACTICE ON THE MENTAL HEALTH PROFILE, OPERATIONALIZED IN THE FORM OF PSYCHOLOGICAL DISTRESS, OF INMATES. METHODS: ONE HUNDRED AND FIFTY-TWO VOLUNTEER PARTICIPANTS (133 MEN; 19 WOMEN) WERE RANDOMLY PLACED IN EITHER OF TWO GROUPS: TO PARTICIPATE IN WEEKLY 90-MIN YOGA CLASS (YOGA GROUP) OR A WEEKLY 90-MIN FREE-CHOICE PHYSICAL EXERCISE (CONTROL GROUP). THE STUDY PERIOD LASTED FOR 10 WEEKS. PRIOR TO AND AT THE END OF THE STUDY PERIOD THE PARTICIPANTS COMPLETED A BATTERY OF SELF-REPORTED INVENTORIES, INCLUDING THE BRIEF SYMPTOM INVENTORY (BSI). RESULTS: PHYSICAL ACTIVITY (INCLUDING YOGA) SIGNIFICANTLY REDUCED THE INMATES' LEVELS OF PSYCHOLOGICAL DISTRESS. YOGA PRACTICE IMPROVED ALL PRIMARY SYMPTOM DIMENSIONS AND ITS POSITIVE EFFECT ON THE OBSESSIVE-COMPULSIVE, PARANOID IDEATION, AND SOMATIZATION SYMPTOM DIMENSIONS OF THE BSI STAYED SIGNIFICANT EVEN WHEN COMPARING WITH THE CONTROL GROUP. CONCLUSIONS: YOGA AS A FORM OF PHYSICAL ACTIVITY IS EFFECTIVE FOR REDUCING PSYCHOLOGICAL DISTRESS LEVELS IN PRISON INMATES, WITH SPECIFIC EFFECT ON SYMPTOMS SUCH AS SUSPICIOUS AND FEARFUL THOUGHTS ABOUT LOSING AUTONOMY, MEMORY PROBLEMS, DIFFICULTY IN MAKING DECISIONS, TROUBLE CONCENTRATING, OBSESSIVE THOUGHT, AND PERCEPTION OF BODILY DYSFUNCTION. 2018 3 2325 56 TREATMENT OF MAJOR DEPRESSIVE DISORDER WITH IYENGAR YOGA AND COHERENT BREATHING: A RANDOMIZED CONTROLLED DOSING STUDY. OBJECTIVES: THE AIMS OF THIS STUDY WERE TO ASSESS THE EFFECTS OF AN INTERVENTION OF IYENGAR YOGA AND COHERENT BREATHING AT FIVE BREATHS PER MINUTE ON DEPRESSIVE SYMPTOMS AND TO DETERMINE OPTIMAL INTERVENTION YOGA DOSING FOR FUTURE STUDIES IN INDIVIDUALS WITH MAJOR DEPRESSIVE DISORDER (MDD). METHODS: SUBJECTS WERE RANDOMIZED TO THE HIGH-DOSE GROUP (HDG) OR LOW-DOSE GROUP (LDG) FOR A 12-WEEK INTERVENTION OF THREE OR TWO INTERVENTION CLASSES PER WEEK, RESPECTIVELY. ELIGIBLE SUBJECTS WERE 18-64 YEARS OLD WITH MDD, HAD BASELINE BECK DEPRESSION INVENTORY-II (BDI-II) SCORES >/=14, AND WERE EITHER ON NO ANTIDEPRESSANT MEDICATIONS OR ON A STABLE DOSE OF ANTIDEPRESSANTS FOR >/=3 MONTHS. THE INTERVENTION INCLUDED 90-MIN CLASSES PLUS HOMEWORK. OUTCOME MEASURES WERE BDI-II SCORES AND INTERVENTION COMPLIANCE. RESULTS: FIFTEEN HDG (MAGE = 38.4 +/- 15.1 YEARS) AND 15 LDG (MAGE = 34.7 +/- 10.4 YEARS) SUBJECTS COMPLETED THE INTERVENTION. BDI-II SCORES AT SCREENING AND COMPLIANCE DID NOT DIFFER BETWEEN GROUPS (P = 0.26). BDI-II SCORES DECLINED SIGNIFICANTLY FROM SCREENING (24.6 +/- 1.7) TO WEEK 12 (6.0 +/- 3.8) FOR THE HDG (-18.6 +/- 6.6; P < 0.001), AND FROM SCREENING (27.7 +/- 2.1) TO WEEK 12 (10.1 +/- 7.9) IN THE LDG (-17.7 +/- 9.3; P < 0.001). THERE WERE NO SIGNIFICANT DIFFERENCES BETWEEN GROUPS, BASED ON RESPONSE (I.E., >50% DECREASE IN BDI-II SCORES; P = 0.65) FOR THE HDG (13/15 SUBJECTS) AND LDG (11/15 SUBJECTS) OR REMISSION (I.E., NUMBER OF SUBJECTS WITH BDI-II SCORES <14; P = 1.00) FOR THE HDG (14/15 SUBJECTS) AND LDG (13/15 SUBJECTS) AFTER THE 12-WEEK INTERVENTION, ALTHOUGH A GREATER NUMBER OF SUBJECTS IN THE HDG HAD 12-WEEK BDI-II SCORES